Therapeutics: Mammalian target of rapamycin (mTOR; FRAP; RAFT1)

In vitro, patient sample and mouse studies suggest inhibiting hyperactivated mutant mTOR could help treat epilepsy in patients with focal cortical dysplasia type II (FCDII). Sequencing of brain tissue...